Searched for
ANJANA ANIL
Gold loses footing as US dollar bumps higher; Fed in focusGold prices retreated on Tuesday, hurt by a strengthening U.S. dollar, while investors geared up for the Federal Reserve's interest rate st...- Gold gains on softer dollar as markets await more Fed cuesGold prices rebounded on Tuesday, helped by a weaker U.S. dollar, while investors looked forward to more U.S. economic data this week that ...
- Gold rises as safe-haven demand, rate cut bets keep prices elevatedGold tends to perform well during economic turmoil, with reliability that can help offset the risk of more volatile assets in conditions su...
- Gold firms on weaker yields as focus turns to US jobs dataData on Tuesday showed U.S. job openings fell to a more than 2-1/2-year low in October, signalling that aggressive rate hikes have started ...
- India's October crude oil imports rise after four months of declinesIndia's fuel consumption also rose to a four-month high in October, as increased industrial activity boosted sales during the festive seaso...
- US adds 6.4 GW of small-scale solar capacity in 2022, EIA saysThe capacity of small-scale solar increased from 7.3 GW in 2014, to 39.5 GW by 2022, the statistical arm of the U.S. Department of Energy s...
- Buy Ajanta Pharma, target Rs 950: Dr CK NarayanBuy Ajanta Pharma Ltd. at a price target of Rs 950.0 and a stoploss at Rs 922 from entry point.
- Sell Ajanta Pharma, target Rs 1040: Dr CK NarayanSell Ajanta Pharma Ltd. at a price target of Rs 1040.0 and a stoploss at Rs 1065 from entry point.
- Buy Ajanta Pharma, target Rs 1225: Manas JaiswalBuy Ajanta Pharma Ltd. at a price target of Rs 1225.0 and a stoploss at Rs 1140 from entry point.
- Sell Ajanta Pharma, target Rs 1075: Kunal BothraSell Ajanta Pharma Ltd. at a price target of Rs 1075.0 and a stoploss at Rs 1125 from entry point.
- Buy Ajanta Pharma, target Rs 1250: Manas JaiswalBuy Ajanta Pharma Ltd. at a price target of Rs 1250.0 and a stoploss at Rs 1160 from entry point.
- Buy Ajanta Pharma, target Rs 1045: Dr CK NarayanBuy Ajanta Pharma Ltd. at a price target of Rs 1045 and a stoploss at Rs 1015 from entry point.
- Buy Ajanta Pharma, target Rs 1060: Kunal BothraBuy Ajanta Pharma Ltd. at a price target of Rs 1060 and a stoploss at Rs 960 from entry point.
- Sell Ajanta Pharma, target Rs 1245: Dr CK NarayanSell Ajanta Pharma, at a price target of Rs 1245 and a stop loss at Rs 1280 from entry point.
- Sell Ajanta Pharma, target Rs 1,080: Sagar DoshiSell Ajanta Pharma at a price target of Rs 1,080 and a stop loss at Rs 1,165 from entry point.
- Buy Ajanta Pharma, target Rs 1275: Dr CK NarayanBuy Ajanta Pharma Ltd. at a price target of Rs 1275.0 and a stop loss at Rs 1245 from entry point.
- Sell Ajanta Pharma, target Rs 1,060: Dharmesh ShahSell Ajanta Pharma at a price target of Rs 1,060 and a stop loss at Rs 1,190 from entry point.
- Sell Ajanta Pharma, target Rs 1195.0 : Dr CK NarayanSell Ajanta Pharma Ltd. at a price target of Rs 1195.0 and a stop loss at Rs 1225 from entry point.
- Eros signs deal with Zee for Rs 50 croreThe big picture is increasingly moving to the small screen as producers rush to sign on big buck deals with general entertainment channels.
- HC rejects Tiwari bail plea in Sarkar murder casePatna High Court on Monday rejected the bail application of former MLA Rajan Tiwari in the CPI-M legislator Ajit Sarkar murder case.
Load More
